Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Damora Therapeutics (DMRA)

$21.26 +$0.17 (+0.81%)

Day’s range
$21.09–$21.78
Volume
641,718

DMRA price history

DMRA closed at $21.26 on Oct. 26, 2026. Over the past year, its daily close ranged from $18.14 on March 20, 2026 to $32.99 on July 20, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $15 to $35, not from zero.
Data table: DMRA daily closes, the past year
DMRA daily closing prices, March 10, 2026 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$21.26
Oct. 23, 2026$21.09
Oct. 22, 2026$21.71
Oct. 21, 2026$21.53
Oct. 20, 2026$20.67
Oct. 19, 2026$19.27
Oct. 16, 2026$18.44
Oct. 15, 2026$18.74
Oct. 14, 2026$18.43
Oct. 13, 2026$18.56
Oct. 12, 2026$20.26
Oct. 9, 2026$21.08
Oct. 8, 2026$20.56
Oct. 7, 2026$20.24
Oct. 6, 2026$19.55
Oct. 5, 2026$20.22
Oct. 2, 2026$20.65
Oct. 1, 2026$20.23
Sept. 30, 2026$21.28
Sept. 29, 2026$20.66
Sept. 28, 2026$20.75
Sept. 25, 2026$20.66
Sept. 24, 2026$20.27
Sept. 23, 2026$20.44
Sept. 22, 2026$22.41
Sept. 21, 2026$22.85
Sept. 18, 2026$22.59
Sept. 17, 2026$22.78
Sept. 16, 2026$24.53
Sept. 15, 2026$24.75
Sept. 14, 2026$28.39
Sept. 11, 2026$28.10
Sept. 10, 2026$26.84
Sept. 9, 2026$26.27
Sept. 8, 2026$29.17
Sept. 4, 2026$30.06
Sept. 3, 2026$28.00
Sept. 2, 2026$28.18
Sept. 1, 2026$28.14
Aug. 31, 2026$28.18
Aug. 28, 2026$29.00
Aug. 27, 2026$30.60
Aug. 26, 2026$30.39
Aug. 25, 2026$30.62
Aug. 24, 2026$30.31
Aug. 21, 2026$30.82
Aug. 20, 2026$30.31
Aug. 19, 2026$32.44
Aug. 18, 2026$31.80
Aug. 17, 2026$31.09
Aug. 14, 2026$31.04
Aug. 13, 2026$30.73
Aug. 12, 2026$31.00
Aug. 11, 2026$30.36
Aug. 10, 2026$29.54
Aug. 7, 2026$29.92
Aug. 6, 2026$29.88
Aug. 5, 2026$30.83
Aug. 4, 2026$30.02
Aug. 3, 2026$28.56
July 31, 2026$28.99
July 30, 2026$29.21
July 29, 2026$28.33
July 28, 2026$29.42
July 27, 2026$29.44
July 24, 2026$28.82
July 23, 2026$29.17
July 22, 2026$29.99
July 21, 2026$32.99
July 20, 2026$32.99
July 17, 2026$31.48
July 16, 2026$30.24
July 15, 2026$30.95
July 14, 2026$30.99
July 13, 2026$28.00
July 10, 2026$28.53
July 9, 2026$30.78
July 8, 2026$27.53
July 7, 2026$30.00
July 6, 2026$29.80
July 2, 2026$29.98
July 1, 2026$27.09
June 30, 2026$26.01
June 29, 2026$24.21
June 26, 2026$25.36
June 25, 2026$22.57
June 24, 2026$22.00
June 23, 2026$22.94
June 22, 2026$23.89
June 18, 2026$21.23
June 17, 2026$21.42
June 16, 2026$20.59
June 15, 2026$20.07
June 12, 2026$20.78
June 11, 2026$21.36
June 10, 2026$20.15
June 9, 2026$20.96
June 8, 2026$20.91
June 5, 2026$21.01
June 4, 2026$22.31
June 3, 2026$22.33
June 2, 2026$22.95
June 1, 2026$24.85
May 29, 2026$24.88
May 28, 2026$24.84
May 27, 2026$25.21
May 26, 2026$25.89
May 22, 2026$25.30
May 21, 2026$24.86
May 20, 2026$24.15
May 19, 2026$24.04
May 18, 2026$24.90
May 15, 2026$24.60
May 14, 2026$23.88
May 13, 2026$24.16
May 12, 2026$23.09
May 11, 2026$24.36
May 8, 2026$24.16
May 7, 2026$24.99
May 6, 2026$24.69
May 5, 2026$24.87
May 4, 2026$25.93
May 1, 2026$25.36
April 30, 2026$25.66
April 29, 2026$23.93
April 28, 2026$24.23
April 27, 2026$25.50
April 24, 2026$24.75
April 23, 2026$25.42
April 22, 2026$25.90
April 21, 2026$26.82
April 20, 2026$26.43
April 17, 2026$26.60
April 16, 2026$27.00
April 15, 2026$26.61
April 14, 2026$26.73
April 13, 2026$26.43
April 10, 2026$25.82
April 9, 2026$26.69
April 8, 2026$25.60
April 7, 2026$24.40
April 6, 2026$24.57
April 2, 2026$25.09
April 1, 2026$25.08
March 31, 2026$25.90
March 30, 2026$24.27
March 27, 2026$25.50
March 26, 2026$25.63
March 25, 2026$25.05
March 24, 2026$23.92
March 23, 2026$23.05
March 20, 2026$18.14
March 19, 2026$19.20
March 18, 2026$21.15
March 17, 2026$24.01
March 16, 2026$24.98
March 13, 2026$26.33
March 12, 2026$26.37
March 11, 2026$26.37
March 10, 2026$25.51

Key figures

52-week range
—
Average daily volume
527,299Past 3 months
Market value
$1.31B
Dividend yield
—
From 52-week high
—

Price change

1 month
+2.90%
3 months
−26.23%
Year to date
—
1 year
—

What Wall Street says about DMRA

In the past 90 days, Wall Street firms published 3 rating or price-target actions on DMRA: 1 reiterated rating and 2 raised price targets.

Rating and price-target actions on DMRA, past 90 days
ActionRating
WedbushReiteratesOutperform$40
GuggenheimRaises targetBuy$40 to $60
WedbushRaises targetOutperform$35 to $40

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Damora Therapeutics, Inc. Ordinary Shares

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Headquarters
Waltham, Mass.
Employees
7
Listed
Oct. 29, 2020
Sector
Health care
Industry
Pharmaceutical preparations

damoratx.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about DMRA is on the site yet.

  • LLYEli Lilly & Co.
  • JNJJohnson & Johnson
  • ABBVABBVIE INC.
  • MRKMerck & Co., Inc.
  • ABTAbbott Laboratories
  • PFEPfizer Inc.